Literature DB >> 9268160

In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization.

C Sunyach1, S Chassot, C Jamard, A Kay, C Trepo, L Cova.   

Abstract

To better understand the role of specific residues within the duck hepatitis B virus (DHBV) pre-S protein in neutralization and infectivity, we have selected and identified pre-S variants which escape neutralization. A highly neutralizing monoclonal antibody (Mab 900) which recognizes an epitope 83IPQPQWTP90 localized previously on the DHBV pre-S protein, within a region suspected to mediate the virus interaction with hepatocytes, was used as immune pressure. After only two in vivo neutralization rounds with Mab 900, five different pre-S mutant genomes were identified, which harbored point mutations affecting only proline residues located at position 90 within this epitope (83IPQPQWTP90) and/or at a distance at position 5. We have shown that a single (P5L) or double proline (P5L + P90H) substitution affect neither virus replication capacity nor in vivo infectivity. However, the P5 mutation reduces mutant recognition by Mab 900 twofold, while the substitution of both prolines 5 and 90 almost completely abolishes mutant P5L + P90H reactivity with this Mab and leads to a decrease of neutralization. Therefore we describe here an experimental system which allows rapid in vivo selection and identification of DHBV pre-S variants and provide evidence that residues within and at a distance from the neutralization epitope are important in DHBV neutralization but do not affect its replication capacity and infectivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268160     DOI: 10.1006/viro.1997.8665

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction.

Authors:  C Sunyach; C Rollier; M Robaczewska; C Borel; L Barraud; A Kay; C Trépo; H Will; L Cova
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Diverse modes of genomic alteration in hepatocellular carcinoma.

Authors:  Suchit Jhunjhunwala; Zhaoshi Jiang; Eric W Stawiski; Florian Gnad; Jinfeng Liu; Oleg Mayba; Pan Du; Jingyu Diao; Stephanie Johnson; Kwong-Fai Wong; Zhibo Gao; Yingrui Li; Thomas D Wu; Sharookh B Kapadia; Zora Modrusan; Dorothy M French; John M Luk; Somasekar Seshagiri; Zemin Zhang
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

3.  Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.

Authors:  Faseeha Noordeen; Catherine A Scougall; Arend Grosse; Qiao Qiao; Behzad B Ajilian; Georget Reaiche-Miller; John Finnie; Melanie Werner; Ruth Broering; Joerg F Schlaak; Andrew Vaillant; Allison R Jilbert
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.